Table 2.
Antimicrobial susceptibility patterns of the 26 isolates confirmed as resistant by E-test.
| Species | AMR Pattern | Isolates, n (%) | |
|---|---|---|---|
| E. coli | AMP/AZT*/CEP/CIP/CTX/ERY*/GEN/MOX*/ STR*/TS* |
1 | 9/49 (18.3%) |
| AMP/CIP/MOX*/STR*/TET*/TS* | 2 | ||
| AMC/AMP | 1 | ||
| STR*/TET* | 2 | ||
| AMP | 1 | ||
| TET* | 2 | ||
| K. pneumoniae | AMP/FOS* | 5 | 7/7 (100%) |
| AMP | 2 | ||
| E. faecium | AMP | 1 | 1/6 (16.7%) |
| E. faecalis | KAN*/STR*/TET* | 2 | 9/24 (33.3%) |
| ERY*/TET* | 1 | ||
| CLY*/TET* | 1 | ||
| TET* | 5 | ||
* Antimicrobials used in the second round of E-test for isolates with one or more ARGs possibly linked to phenotypic resistance. AMP = ampicillin, AZT = azitromycin, CEP = cefepime, CIP = ciprofloxacin, CLY = clindamycin, CTX = cefotaxime, ERY = erythromycin, FOS = fosfomycin, GEN = gentamicin, MOX = moxifloxacin, STR= streptomycin, TET = tetracyclin.